Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Natural products for hyperlipidemia

July 11, 1997

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

Interleukin-11 reviewed

July 11, 1997

FDA clears Bayer's cholesterol-lowering agent

July 10, 1997

Exocell presents humanized MAb for diabetic nephropathy

July 10, 1997

Novel hemoregulatory compounds from SKB

July 10, 1997

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

July 9, 1997

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...